Predictive value of the systemic immune-inflammation index for the efficacy of neoadjuvant chemotherapy and prognosis in patients with stage III ovarian cancer-a retrospective cohort study.

Gland Surg · 2022 · PMC9638786 · PMID 36353589

Europe PMC DOI

hedged sentence

0.3020

closest p · 6.0× alpha

0.3020

boldest claim

The sentences

did not reach statistical significanceP=0.302not close (p > 0.1)

Correlation between neoadjuvant chemotherapy efficacy and progression-free survival The progression-free survival of patients who achieved complete response after neoadjuvant chemotherapy tended to be longer, but the difference did not reach statistical significance (P=0.302) ( Figure 6 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.